The International Consortium on Meningiomas (ICOM) is hosting a scientific day on Tuesday, May 21 as part of CNSF. Led by Dr. Gelareh Zadeh, this consortium was formed to increase awareness for this understudied disease and conduct cutting-edge meningioma research through international and multidisciplinary collaboration. This meeting’s program will feature updates on ongoing collaborative research as well as a practical overview of modern meningioma management, with themes including surgical management, biomarkers, clinical trials updates and more. We will also host a molecular tumour board where complex cases are reviewed by an expert multidisciplinary panel with opportunity for audience involvement. These sessions will be highly relevant to anyone involved in meningioma research or clinical care and all are welcome to attend.
Learn more on ICOM https://www.meningiomaconsortium.com
Scientific Committee
To submit an abstract for ICOM, please complete form below.
ICOM Abstract Submission
ICOM Agenda
Moderators:
8:00 - 8:05
Overview of ICOM: Meningioma Consortium and 100th Anniversary of Neurosurgery
Gelareh Zadeh
Professor and Dan Chair
Division of Neurosurgery, Department of Surgery, Temerty Faculty of Medicine University of Toronto
Head of Neurosurgery, Toronto Western Hospital
8:05 - 8:20
Sex and Racial Disparities in Meningioma
Quinn T. Ostrom
Assistant Professor
Duke University School of Medicine
8:20-8:30
Understanding the Intersection of Race, Sex, and Genomic Profiles in Meningioma
Alper Dincer
Resident
Tufts Medical Center
8:30 - 8:45
Tumour Microenvironment of Meningioma
Christel Herold-Mende
Professor
Heidelberg University
8:45 - 8:55
Epigenomic Drivers of Meningioma
Mark Youngblood
Resident
Northwestern University
8:55 - 9:05
Metabolic Landscape of Aggressive Meningioma
Alex Landry
Resident
Division of Neurosurgery, Department of Surgery, Temerty Faculty of Medicine University of Toronto
9:05 - 9:20
Discussion/Break
9:20 - 9:35
Predictive Signatures for Meningiomas
Akash J. Patel
Associate Professor
Baylor College of Medicine
9:35 - 9:45
Role of Radiotherapy for Meningioma
Justin Wang
Resident
Division of Neurosurgery, Department of Surgery, Temerty Faculty of Medicine University of Toronto
9:45 - 10:00
Biomarkers of Radiation Response
David R. Raleigh
Associate Professor
University of California San Francisco
10:00 - 10:15
Role of Liquid Biopsy
Houtan Noushmehr
Associate Professor
Henry Ford Health System
10:15 - 10:30
Update on EANO Guidelines for Molecular Testing, Biomarker Consortium
Susan Short
Professor
University of Leeds
10:30 - 10:45
Break
10:45 - 11:00
Health-related Quality of Life in Meningioma
Tobias Walbert
Associate Professor
Henry Ford Health Systems
11:00 - 11:15
Development and Validation of a Quality of Life Questionnaire for Meningioma
Michael Cusimano
Professor
Division of Neurosurgery, Department of Surgery, Temerty Faculty of Medicine, University of Toronto
St. Michael’s Hospital
11:15 - 11:30
Neurocognitive, Psychological, and Functional Outcomes in Patients with Meningioma
Angela Sekely
Fellow
Princess Margaret Cancer Centre
11:30 - 11:45
International Tuberculum Sellae Meningioma Study
Michael W. McDermott
Professor
Baptist Health
11:45 - 12:00
Role of Preoperative Embolization
Vitor Mendes Pereira
Professor
Division of Neurosurgery, Department of Surgery, Temerty Faculty of Medicine, University of Toronto
St. Michael's Hospital
12:00 - 12:15
Endoscopic Anatomy From An ENT Perspective
Ian Witterick
Professor
Department of Otolaryngology - Head & Neck Surgery
Mount Sinai Hospital
12:15 - 1:00
Lunch
Moderators:
1:00 - 2:00
Molecular Tumour Board
Speakers:
2:00 - 2:15
cIMPACT Update
Felix Sahm
Consultant
University Hospital Heidelberg
2:15 - 2:30
Evaluating Immunohistochemical Surrogates for Meningioma Molecular Subtypes
P.J. Cimino
Head, Neuropathology Unit
Surgical Neurology Branch, NINDS
2:30 - 2:40
Outcomes in Grade 3 Meniningioma
Alexander Rebchuk
Resident
University of British Columbia
2:40 - 2:55
Updates on Molecular Pathology of Meningioma/WHO Grading
Stephen Yip
Associate Professor
University of British Columbia
2:55 - 3:10
Mutation Landscape of Meningioma Grade Progression
Kate Drummond
Professor, Director of Neurosurgery
Royal Melbourne Hospital
3:10 - 3:25
DOTATATE- PET and Theranostics of Meningioma: European Update
Joerg-Christian Tonn
Professor
Ludwig-Maximilians-University of Munich
3:25 - 3:40
Clinical Trial Design of Theranostics of Meningioma - North American Update
Erik P. Sulman
Professor and Vice-Chair of Research
NYU Grossman School of Medicine
3:40 - 3:55
Alliance Trials and Opportunities: The Role of Umbrella Trials in Meningioma
Evanthia Galanis
Professor
Mayo College of Medicine
3:55 - 4:10
Radiation versus Observation for Atypical Meningioma: update from the ROAM/EORTC1308 trial
Michael D. Jenkinson
Professor
The Walton Centre NHS Foundation Trust, Department of Neurosurgery
4:10 - 4:15
Discussion/ Closing Remarks
Gelareh Zadeh
Professor and Dan Chair
Division of Neurosurgery, Department of Surgery, Temerty Faculty of Medicine University of Toronto
Head of Neurosurgery, Toronto Western Hospital